NASDAQ:TLMD

SOC Telemed (TLMD) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$3.00
$3.00
50-Day Range
$2.90
$3.00
52-Week Range
$0.55
$8.00
Volume
N/A
Average Volume
1.28 million shs
Market Capitalization
$302.52 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
TLMD stock logo

About SOC Telemed Stock (NASDAQ:TLMD)

SOC Telemed, Inc. provides acute care telemedicine services and technology to hospitals, health systems, physician groups, and government organizations in the United States. The company's Telemed IQ, a cloud-based software platform provides telemedicine solutions. Its telemedicine solutions include teleNeurology, telePulmonology, telePsychiatry, telecardiology, teleCritical Care (ICU), and other specialties. The company was founded in 2004 and is based in Herndon, Virginia. As of April 6, 2022, SOC Telemed, Inc. was taken private.

TLMD Stock News Headlines

SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
Securonix Appoints Eunice Kim as General Counsel
[Shocking] Elon Musk’s Plan To End Banks
Leaked Elon Musk call reveals shocking plan to replace banks. As Musk's plan rolls out, industry experts predict it could spark a wave of mass crypto adoption. Triggering a new crypto bull run. While helping drive a booming crypto asset class up from $2.5-billion to $16-trillion (a 6,400x increase) by 2030.
TLMD Historical Data
Building Society in Banking: Meaning and Examples
SEMIFIVE Announces New 5nm HPC SoC Platform
See More Headlines
Receive TLMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SOC Telemed and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/12/2021
Today
4/22/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Miscellaneous Health & Allied Services
Sub-Industry
N/A
Current Symbol
NASDAQ:TLMD
Fax
N/A
Employees
226
Year Founded
N/A

Profitability

Net Income
$-50,540,000.00
Pretax Margin
-53.68%

Debt

Sales & Book Value

Annual Sales
$94.44 million
Book Value
$1.66 per share

Miscellaneous

Free Float
93,882,000
Market Cap
$302.52 million
Optionable
Optionable
Beta
-1.44
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Dr. Christopher M. Gallagher FACC (Age 42)
    M.D., CEO & Director
    Comp: $1.42M
  • Mr. David Mikula M.B.A. (Age 52)
    Chief Operating Officer
    Comp: $411.88k
  • Dr. R. Jason Hallock M.D. (Age 50)
    Chief Medical Officer
    Comp: $424.62k
  • Mr. David R. Fletcher (Age 62)
    Interim Chief Financial Officer
  • Ms. Erica St. Angel
    Chief Information Officer & Sr. VP of Infrastructure
  • Mr. Steven Rubis
    VP of Investor Relations
  • Ms. Eunice J. Kim (Age 48)
    Gen. Counsel & Corp. Sec.
  • Ms. Meg Hoyecki
    VP of Marketing
  • Ms. Nichole Robb
    Director of HR
  • Dr. Andy Barbash
    Chief of Neurology

TLMD Stock Analysis - Frequently Asked Questions

How were SOC Telemed's earnings last quarter?

SOC Telemed, Inc. (NASDAQ:TLMD) released its quarterly earnings data on Friday, November, 12th. The company reported ($0.11) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.20) by $0.09. The business had revenue of $26.68 million for the quarter, compared to analysts' expectations of $25.90 million. SOC Telemed had a negative trailing twelve-month return on equity of 34.32% and a negative net margin of 53.52%. During the same period in the previous year, the business posted ($0.14) earnings per share.

This page (NASDAQ:TLMD) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners